NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Advent France Biotechnology

Advent France Biotechnology

Paris, Île-de-Franceadbio.partners

Overview

Advent France Biotechnology is a venture capital firm that invests in a range of sectors within the life sciences - specifically in therapeutics-oriented projects. AFB's unique strategy combines early-stage investments in promising enterprises and strong entrepreneurial support to strengthen the company's growth. As an early-stage investor, they act as a catalyst to create companies based on innovations coming from academic research. They have established relationships with leading research institutions and technology transfer offices in Europe and benefit from the support of a strong network of scientific, clinical, industry and financial partners.

Year Founded

2015

AUM

$65M

Portfolio Companies

10

Investments

Advent France Biotechnology investments
CompanyDateStageLead
ARTHEx BiotechSep 2025Series BCo-investor
IntegraTherapeuticsSep 2025VC RoundCo-investor
Augustine TherapeuticsMar 2025Series ACo-investor
Augustine TherapeuticsJun 2024Series ACo-investor
AstraveusJun 2023SeedLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersParis, Île-de-France
Year Founded2015
AUM$65M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.